Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Heparin MeSH Descriptor Data 2026


MeSH Heading
Heparin
Tree Number(s)
D09.698.373.400
Unique ID
D006493
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006493
Scope Note
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
Entry Term(s)
Heparin Sodium
Heparinic Acid
Liquaemin
Sodium Heparin
Unfractionated Heparin
alpha-Heparin
Pharm Action
Anticoagulants
Fibrinolytic Agents
Registry Numbers
9005-49-6
0
NLM Classification #
QV 193
Public MeSH Note
/therapeutic use was HEPARIN, THERAPEUTIC 1965
History Note
/therapeutic use was HEPARIN, THERAPEUTIC 1965
Entry Combination
antagonists & inhibitors:Heparin Antagonists
Date Introduced
1960/01/01
Last Updated
2010/06/25
Heparin Preferred
Sodium Heparin Narrower
alpha-Heparin Narrower
Liquaemin Narrower
page delivered in 0.141s